Survey from patients and institutions with experience of cancer genomic profiling tests.

JRCT ID: jRCT1030210547

Registered date:13/01/2022

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Malignant solid tumors
• Date of first enrollment: 31/03/2021
• Target sample size: 4400
• Study type: Observational

Outcome(s)

Primary Outcome

The details of patients who experience cancer genomic profiling tests
The ratio of patients who can receive genome-matched therapies
Levels of comprehension and satisfaction of the patients

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Both

Include criteria

Cancer patients with experience of cancer genomic profiling tests under health insurance or Advanced Medical Care, Category B in Japan.
Patients who agree to answer the survey. Parental or other representative agreement is acceptable when the informed consent from the patient is difficult such as in pediatric cancer patients.

Exclude criteria

Patients who was tested in hospitals that do not participate in this survey.
Patients who decliene to answer this survey.
Absence of parental or other representative agreement in pediatric cancer patients.

Related Information

• Primary Sponsor: Seto Yasuyuki
• Secondary Sponsor: Oda Katsutoshi,Kage Hidenori,Ushiku Aya
• Source(s) of Monetary Support: The Ministry of Health Labour and Welfare, Health Labour Sciences Research Grant